维生素K2市场Share, Size, Trends, Industry Analysis Report By Source (Synthetic, Natural); By Product (MK-7, MK-4, Others); By Application (Pharmaceuticals, Nutraceuticals & Food, Others); By Regions, Segments & Forecast, 2020 - 2026

Report Summary

The global vitamin K2 market was valued at USD 54.90 million in 2019 and is expected to grow at a CAGR of 24.5% over the forecast period. The letter “K” in the term Vitamin K represents the Danish word ‘koagulation’, which means the ability to prevent clot blood. Found mainly in dairy products, it is also technically classified as ‘menaquinones’, a group of compounds. The product is presently being tested worldwide in government laboratories as well as private R&D units for its scope in cancer treatment, cognition, vascular calcification, osteoarthritis and osteoporosis.

全球市场的特点是现有市场参与者建立了广泛的供应渠道，其中每个公司使用略微或完全不同的供应协议。大多数盛行的主要市场参与者签署了长期合同，与巨型区域以及当地销售代理商，他确保了一致和广泛的产品来源，从而加强了国际市场的职位。然而，与这种趋势一样，中国和印度制造商在直接销售中投入了更多的努力和金钱。

Know more about this report:请求样本页面

维生素K广泛用于各种最终用途，但主要用于减少炎症;因此，预计市场将主要是因为人类发生的维生素缺乏症状。推进市场增长的其他因素包括骨质疏松症的上升案例，审美标准的增加，消费营养补充剂的需求飙升，以及人类的整体健康意识。然而，对补充认可和测试的不利和严格的政府法规可能对制造商构成挑战。

Growing health consciousness among people has in turn increased the demand for functional foods and diet supplements. According to some studies, the intake of Vitamin K2 MK-4 is deemed safe if consumed in appropriate limits, and does not lead to hyper-coagulation. Also, in cases of rheumatoid arthritis, Vitamin K2 intake lowers CRP levels. Vitamin K2 MK-7 is commonly used as a supplement additive. It can also be found in a traditional Japanese food “Natto”. Natto is a foodstuff which is produced from fermented soybeans with the help of different types of bacteria, including propionic acid bacteria and lactic acid bacteria.

维生素K2市场Report Scope

The market is primarily segmented on the basis of Source, Product, Application, Form, and geographic region.

通过来源	By Product	By Application	By Region
Natural Synthetic	MK-4. MK-7. 其他	Pharmaceuticals 营养食品和食品 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Russia) Asia Pacific (China, India, Japan, Korea) Latin America (Mexico, Brazil, Colombia) MEA (Saudi Arabia, Israel)

Know more about this report:请求样本页面

Source Outlook

截至2019年，近68％的K2 MK-7成分制造基于发酵过程，而其余部分是通过合成过程进行的。然而，该百分比易受该预测期的可测量变化的影响。发酵过程比合成生产相对较低的益处。在储存架上看到的多达90％的维生素使用合成过程制造。这是一个重要的要点，因为可以通过技术创新实现大众市场商业化，例如维生素的合成。

根据临床研究，维生素K2发酵过程所源的产物最适合改善健康绝经后妇女的骨密度，以及逆转和预防动脉钙化。与天然维生素K2相比，大多数现有市场参与者目前生产的合成维生素K2几乎是较高的两倍。

产品展望

Vitamin K2 comprises of various subtypes, most commonly identified as menaquinone-n (MK-n), where ‘N’ represents the number of isoprenyl groups. When compared with MK-7, Vitamin K2 MK-4 exhibits lower bioactivity and bioavailability. In most of the cases, synthetic Vitamin K2 MK-4 is used for pharmacological purposes.

大多数公司在中国和印度不哈ve an international brand influence and hence are not yet recognized. However, they exercise a price advantage over other brand and rely on B2C sales instead of B2B sales to strengthen personal consumer connect.

与维生素K1一样，包括动物肝脏和发酵食品的几种维生素K2的普遍普遍存在的源泉，不能充分满足维生素K2所需的常规膳食需求。然而，与维生素K1相比，由于其经过验证的适用性在治疗冠心病方面，维生素K2具有有利可图的范围。

应用前景

A major chunk of the global demand for them is anticipated to be triggered on account of the increasing prevalence of osteoporosis. Osteoporosis affects umpteen people across the planet leaving them in a huge financial burden and shortened life span, basically occurring in humans as a result of lack of vitamin K deficiency. It has also proven to ease the pain of bone fractures in women experiencing menopause.

It is mainly consumed in two forms, powders and oils. Depending on the orientation of end-use, they can be consumed in food products, health and dietary supplements, functional foods, injections, tablets, and syrups. The ever-increasing research around the ingredient is expected to surge the demand for vitamin K2 in untapped markets as well.

Regional Outlook

在市场份额方面，北美市场成为2019年最大的一个，并预计将在预测期内维持其等级。由于由于加拿大和美国等发达国家的危及生育公民的广泛存在，主要预计将在膳食和食品补充申请部门中引发区域需求。

德国和英国制造商遵循的重要步骤与成分周围的研发有关，使欧洲能够在全球市场中占据第二大市场份额。亚太地区的临床试验和健康意识人数上涨可能在未来五年内为APAC制定增长增长。从整体观点来看，预计骨质疏松症患病率的增加将进一步引发全球对维生素K2的主要需求。

竞争格局

全球维生素K2市场中的显着球员包括Kappa Bioscience，Danisco A / S（杜邦营养和健康），巴斯夫，DSM，Nattropharma，辉瑞公司，帝斯曼和Kikkcoman Corporation。兼并和收购（并购），合作，伙伴关系和新产品开发是这些市场参与者实施的主要增长战略，这些竞选人员在经济中维持其领先地位。

In May 2018, Kappa Bioscience in association with other partner companies launched a product line of seven new “K2VITAL” white-label vitamin K2 products. These were primarily introduced with an intention of addressing peculiar consumer problems in a novel way. Kappa Bioscience’s product K2Vital Delta is produced using BASF’s beadlet technology. Also, in November 2017, NattoPharma undertook a strategic initiative to increase their presence in China by launching a Vitamin K2 product MenaQ7 in a regional conference of product distributors. The product was eyed by nearly 170 Chinese distributors, and has reached most of the Chinese territories as of 2019.